• WST-8 Glucose Uptake Assay Kit Guide

  2026-09-02

  The WST-8 Glucose Uptake Assay Kit provides non-radioactive, colorimetric measurement of cellular glucose uptake through a 2-deoxyglucose-dependent NADPH signal. The glucose uptake assay reports a 450 nm formazan readout and manufacturer-reported linearity from 10 to 500 μM under stated assay conditions.

• Angiotensin 1/2 (1-6) in RAS Assays

  2026-09-02

  Angiotensin 1/2 (1-6), the Asp-Arg-Val-Tyr-Ile-His hexapeptide, gives cardiovascular, renal, and receptor-binding researchers a defined tool for dissecting peptide-dependent signaling. Its high reported solubility supports flexible aqueous or DMSO workflows, while recent spike–receptor findings create a carefully bounded extension into viral-binding assays.

• Berbamine hydrochloride for Cell Assay Reliability

  2026-09-01

  This scenario-based guide explains how Berbamine hydrochloride (SKU N2471) can support reproducible viability, proliferation, and cytotoxicity experiments in KU812 and HepG2 models. It connects product specifications with assay design, concentration selection, ferroptosis context, data interpretation, and practical vendor evaluation.

• AMPK–JAK2/STAT3 Axis in Obesity-Related Asthma

  2026-09-01

  The reference study identifies reduced AMPK activity and M1 macrophage polarization as linked features of obesity-related asthma, connecting metabolic sensing with airway inflammation through JAK2/STAT3 signaling. Its combined mouse and cell-based design supports AMPK activation as a mechanistic research strategy, while leaving important questions about human translation and pathway specificity.

• Ciprofloxacin: Mechanism to AMR Translation

  2026-08-31

  Ciprofloxacin can serve as both a mechanistic probe and a translational benchmark in antimicrobial resistance research. By connecting DNA replication inhibition with plasmid-mediated carbapenem resistance, this article shows how researchers can move from susceptibility testing to transmission-aware bacterial infection models and more decision-ready experimental strategies.

• MCC950 sodium: Practical NLRP3 Workflows

  2026-08-31

  MCC950 sodium enables selective interrogation of NLRP3 signaling across macrophage, PBMC, and neuroinflammation workflows. This guide translates its reported potency into assay design, phenotype-resolved experiments, and troubleshooting strategies for inflammatory disease research.

• Meropenem in Carbapenem Resistance Research

  2026-08-30

  Meropenem is a β-lactam antibiotic carbapenem that can serve as both an antibacterial perturbation and a phenotype anchor in resistance research. This guide connects its PBP-directed activity with carbapenemase gene transmission, isolate stratification, and reproducible Gram-negative infection models.

• Beyond Viability: Better Cancer Drug Response Metrics

  2026-08-29

  Hannah R. Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. By separating growth inhibition from cell killing and considering their timing, the study provides a more interpretable framework for in vitro drug-response experiments.

• MAPK10–KRT16 Control of NSCLC Metastasis

  2026-08-28

  The reference study identifies a phosphorylation-dependent MAPK10/KRT16/RNF213 pathway that limits non-small cell lung cancer metastasis by directing KRT16 toward ubiquitin-mediated degradation. Its combination of mechanistic protein analysis, metastasis models, pharmacologic rescue, and clinical correlation provides a framework for evaluating KRT16 turnover as a biomarker and therapeutic vulnerability.

• Rifampin Workflows for Transcription Control

  2026-08-28

  Rifampin provides a practical, mechanistically defined way to interrupt bacterial transcription for resistance mapping, RNA-dynamics assays, and synthetic biology validation. This guide connects its DNA-dependent RNA polymerase activity with assay design lessons from a light-inducible mammalian translation switch, while clearly separating established evidence from exploratory cross-domain applications.

• Dihydroethidium Workflow for Live-Cell Superoxide

  2026-08-27

  Dihydroethidium (DHE), also called hydroethidine, turns intracellular superoxide-associated oxidation into a practical red-fluorescence readout for live-cell experiments. This workflow connects assay setup, controls, and troubleshooting to skin-aging research while showing how the same oxidative stress assay can be adapted to apoptosis and cardiovascular disease research.

• DPPH Radical: Antioxidant Screening Guide

  2026-08-27

  DPPH, or 2,2-Diphenyl-1-Picrylhydrazyl, is a stable nitrogen-centered radical used for rapid colorimetric antioxidant screening. Its absorbance decrease provides an in vitro ranking signal for electron- or hydrogen-donating activity, but it does not establish cellular protection, pharmacological efficacy, or a specific molecular target.

• 2'-O-Methyladenosine: Evidence and Workflows

  2026-08-26

  2'-O-Methyladenosine is a 2′-O-methylated adenosine derivative used in RNA modification nucleosides, purine metabolism studies, and nucleoside analog research. Its strongest evidence base is analytical: isotope-diluted UHPLC–MS/MS can resolve and quantify methylated purines in complex cellular matrices, while functional and translational claims require assay-specific validation.

• DRG1, c-Myc Phosphorylation, and Lenvatinib Resistance

  2026-08-26

  A pre-proof study in Cellular Signalling integrates single-cell and spatial transcriptomics with clinical validation, functional experiments, and xenograft models to define DRG1 as a driver of hepatocellular carcinoma progression. The findings place DRG1 within an HDAC2–DRG1–c-Myc regulatory axis and indicate that DRG1 depletion may improve lenvatinib response, while also identifying important questions for biomarker validation and translational testing.

• Pentoxifylline Workflows for Inflammation

  2026-08-25

  Build reproducible monocyte, macrophage, PBMC, psoriasis, and infection-model assays around Pentoxifylline, a non-specific phosphodiesterase inhibitor that connects cAMP elevation with inflammatory readouts. This guide emphasizes concentration selection, ICAM-1 and cytokine measurements, mechanistic controls, and practical troubleshooting rather than treating one dose as universally optimal.

8273 records 1/552 page Next 12345 下5页 Last page